Home β€Ί Stock analysis β€Ί DRTSW

Alpha Tau Medical (DRTSW) Stock: Why It's Up Today

Updated Oct 19, 2026, 4:00 PM ET Β· closing price

What changed since yesterday

DRTSW jumps 10.1% to $2.95. Closed at $2.95, +10.07% vs the prior close of $2.68. Day range $2.65–$3.02, opened at $0.33.

Last close$2.95+10.07%
Day range2.65–3.02
Open0.33
Volume33.92K
52-week range2.36–3.02
Avg volume (20d)38.64K

DRTSW daily analysis β€” what happened

A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.

Oct 19, 2026 β€” DRTSW jumps 10.1% to $2.95

DRTSW bull case vs bear case (from the data)

Bull case
  • No clear positive signal in the price trend, filings or insider data right now.
Bear case
  • Insider selling outweighs buying: 25 sales vs 0 open-market buys among the 25 most recent reported insider trades (Form 4, last 12 months).
  • High volatility: average daily move of 10.1% over 20 sessions.
  • Thin trading (under $2M a day on average) can mean wide bid/ask spreads.

DRTSW latest news & SEC filings

Every SEC filing by or about DRTSW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 19, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-110531

Aug 31, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-095370

Aug 25, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001213900-26-093335

Aug 21, 2026 Β· Form 144 β€” Planned insider sale

Notice of proposed sale (Form 144) β€” an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001976408-26-000759

Aug 12, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001213900-26-088176

Aug 10, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-087224

Aug 10, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-086947

Jul 21, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-079822

Jul 15, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-078138

Jul 7, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001213900-26-075747

Jul 6, 2026 Β· Form 144 β€” Planned insider sale

Notice of proposed sale (Form 144) β€” an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001976408-26-000638

Jul 6, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001213900-26-075309

Jun 25, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-072034

Jun 23, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-071076

Things to know before you trade DRTSW

DRTSW market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 19, 20260.333.022.652.9533.92K
Oct 16, 20260.332.972.362.6843.37K

About Alpha Tau Medical

Alpha Tau Medical (DRTSW) is listed on the Nasdaq and classified by the SEC under β€œSurgical & Medical Instruments & Apparatus”. Its business address is in JERUSALEM, Israel. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1871321.

DRTSW board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Alan AdlerDirectorMar 18, 2026
Ruth AlonDirectorMar 18, 2026
Michael AvruchDirectorMar 18, 2026
S Morry BlumenfeldDirectorMar 18, 2026
Nadav KidronDirectorMar 18, 2026
David Mark MilchDirectorMar 18, 2026
Maya NetserDirectorMar 18, 2026
Uzi SoferChief Executive OfficerMar 18, 2026

Executive officers

NameTitleLatest filing
Raphi LevyChief Financial OfficerAug 25, 2026
Uzi SoferChief Executive OfficerMar 18, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Aug 21, 2026Raphi LevySale2,871$15.00
Aug 21, 2026Raphi LevySale2,871$15.00
Aug 21, 2026Raphi LevySale2,871$15.00
Aug 21, 2026Raphi LevySale2,871$15.00
Aug 11, 2026Raphi LevySale17,730$14.00
Aug 11, 2026Raphi LevySale17,730$14.00
Aug 11, 2026Raphi LevySale17,730$14.00
Aug 11, 2026Raphi LevySale17,730$14.00
Jul 6, 2026Raphi LevySale2,270$14.00
Jul 6, 2026Raphi LevySale2,270$14.00
Jul 6, 2026Raphi LevySale2,270$14.00
Jul 6, 2026Raphi LevySale2,270$14.00
Jul 2, 2026Raphi LevySale17,873$13.00
Jul 2, 2026Raphi LevySale17,873$13.00
Jul 2, 2026Raphi LevySale17,873$13.00

DRTSW financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

DRTSW earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Surgical & Medical Instruments & Apparatus

Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)MiniMed (MMED)Medline (MDLN)Becton Dickinson (BDX)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)

More on DRTSW

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.